Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05233839
Other study ID # Mugla
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 15, 2022
Est. completion date July 15, 2022

Study information

Verified date August 2022
Source Mugla Sitki Koçman University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to compare the home exercise program performed with video-based telerehabilitation in patients with degenerative meniscal injury, and the home exercise program performed with one-on-one training in the hospital with conventional methods.


Description:

Conventional rehabilitation (CR) practices will be applied to the first study group. Telerehabilitation (TR) application will be applied to the second study group. It is aimed to evaluate the patients in terms of pain, functionality, quality of life and exercise compliance.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date July 15, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Male and female patients aged 18 - 65 years - Having been diagnosed with degenerative meniscus injury by an orthopedist by MRI examination - Having signed the consent form Exclusion Criteria: - Situations that will prevent assessments or communication with the individual - Having an operation due to degenerative meniscus injury problem - Orthopedic and neurological problems that would prevent evaluation and/or treatment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Telerehabilitation
Application based video home exercise for the degenerative meniscus injury
Paper Based Rehabilitation
Paper instruction based home exercise for the degenerative meniscus injury

Locations

Country Name City State
Turkey Mugla Sitki Koçman Training and Research Hospital Mugla Mentese

Sponsors (1)

Lead Sponsor Collaborator
Mugla Sitki Koçman University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analog Scale (VAS) On a 10 cm straight line or numerical scale (0: no pain, 10: unbearable pain). Change from Baseline VAS at 8 weeks
Primary Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) WOMAC consists of 3 main headings: pain intensity, stiffness, and physical function. The total score ranges from 0 (no disability) to 96 (complete disability). Change from Baseline WOMAC at 8 weeks
Primary SF-12 SF 12 is a self-evaluation scale. It consists of seven items. Its score ranged from 0 to 100, with higher scores indicating better physical and mental health functioning. Change from Baseline SF-12 at 8 weeks
Primary Muscle Strength Test with Lafayette Hand Held Dynamometer It is an objective muscle strength measurement tool. Measurements are made 3 times. A rest of 120 seconds is given between measurements. The highest measured value is noted. Change from Baseline Dynamometer Value at 8 weeks
Primary Proprioception Measurement with Baseline Bubble Inclinometer The "absolute angle difference", which is the difference between the targeted angle and the angle realized by the patient in each repetition, is recorded. The arithmetic mean of the absolute angle difference of 3 repetitions is the result data. Change from Baseline Inclinometer Value at 8 weeks
Secondary EARS In order to observe the individual's adaptation to exercise, the motivation levels of the patients regarding the exercise program are evaluated with the exercise diary prepared by the researchers of the study. It is scored between 0 to 24. Higher scores indicate greater adherence. Change from Baseline EARS at 8 weeks
Secondary TSUQ It consists of 21 items. With this survey, the satisfaction levels and usability of individuals using the telemedicine service are evaluated. The total score is scored between 17 and 85. Higher scores indicate higher satisfaction and usability. Change from Baseline TSUQ at 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05882591 - Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment N/A
Completed NCT06308887 - Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis Phase 4
Recruiting NCT04972331 - Degenerative Meniscus Without Osteoarthritis : Arthroscopic Partial Menisectomy Versus Platelet Rich Plasma (APM-PRP) N/A
Enrolling by invitation NCT04641351 - Corticosteroid Meniscectomy Randomized Trial Phase 4
Recruiting NCT05261360 - Clinical Efficacy of Exosome in Degenerative Meniscal Injury Phase 2
Recruiting NCT03953846 - NUsurface Implant Registry
Completed NCT04837456 - Metabolic Syndrome and Degenerate Meniscus Tears N/A
Recruiting NCT05128851 - High Tibial Osteotomy With/Without Arthroscopy. N/A
Completed NCT01712191 - Treatment of the Medial Meniscus With the NUsurface(R) Meniscus Implant N/A
Not yet recruiting NCT05501197 - Effects of Different Telerehabilitation Methods on Pain, Functional Limitation, Muscle Strength, Balance, and Quality of Life in Patients With Meniscus Degeneration N/A